Adjuvant aromatase inhibitor therapy and early markers for cardiovascular disease in breast cancer survivors

被引：0
作者：
Annemiek van Ommen-Nijhof
Judy N. Jacobse
Lars C. Steggink
Joop D. Lefrandt
Jourik A. Gietema
Flora E. van Leeuwen
Michael Schaapveld
Gabe S. Sonke
机构：
[1] The Netherlands Cancer Institute,Department of Medical Oncology
[2] Leiden University Medical Center,Department of Radiotherapy
[3] Erasmus University Medical Center,Department of Medical Oncology
[4] University Medical Center Groningen,Department of Internal Medicine
[5] University Medical Center Groningen,Department of Medical Oncology
[6] The Netherlands Cancer Institute,Department of Psychosocial Research and Epidemiology
[7] The Netherlands Cancer Institute,Department of Medical Oncology
[8] University of Amsterdam,Department of Medical Oncology
来源：
Breast Cancer Research and Treatment | 2022年 / 196卷
关键词：
Breast cancer; Endocrine therapy; Aromatase inhibitor; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：591 / 602
页数：11
相关论文
共 184 条
[21]  
Hasenburg A(2020)Myocardial dysfunction in long-term breast cancer survivors treated at ages 40–50 years Eur J Heart Fail 22 1194-220
[22]  
Vannetzel JM(2018)Optimal adjuvant endocrine treatment of ER+/HER2+ breast cancer patients by age at diagnosis: a population-based cohort study Eur J Cancer 90 261-267
[23]  
Buzdar A(2013)Skin autofluorescence, a non-invasive marker for AGE accumulation, is associated with the degree of atherosclerosis PLoS One 8 e23-31
[24]  
Howell A(2019)Early breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up† Ann Oncol 30 579-587
[25]  
Cuzick J(2016)Treatment with aromatase inhibitors and markers of cardiovascular disease Breast Cancer Res Treat 160 541-547
[26]  
Wale C(2016)Effect of aromatase inhibitor therapy on the cardiovascular health of black and white breast cancer patients Clin Breast Cancer 16 687-693
[27]  
Distler W(2019)Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients Korean J Intern Med 34 R35-1782
[28]  
Hoctin-Boes G(2017)Vascular function in breast cancer survivors on aromatase inhibitors: a pilot study Breast Cancer Res Treat 166 1777-217
[29]  
Grey AB(2018)Attenuated peripheral endothelial function among women treated with aromatase inhibitors for breast cancer Coron Artery Dis 29 211-21
[30]  
Stapleton JP(2009)Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy Breast Cancer Res 11 11-559
12345678910